I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
First-Time Disclosure of CVN424, a Potent and Selective GPR..:
Huikai Sun (2037619)
;
Holger Monenschein (1822072)
;
Hans H. Schiffer (10660697)
...
https://figshare.com/articles/journal_contribution/First-Time_Disclosure_of_CVN424_a_Potent_and_Selective_GPR6_Inverse_Agonist_for_the_Treatment_of_Parkinson_s_Disease_Discovery_Pharmacological_Validation_and_Identification_of_a_Clinical_Candidate/14439410. , 2021
Link:
https://doi.org/10.1021/acs.jmedchem.0c02081.s001
RT Journal T1
First-Time Disclosure of CVN424, a Potent and Selective GPR6 Inverse Agonist for the Treatment of Parkinson's Disease: Discovery, Pharmacological Validation, and Identification of a Clinical Candidate
UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonian:oai:figshare.com:article_14439410&Exemplar=1&LAN=DE A1 Huikai Sun (2037619) A1 Holger Monenschein (1822072) A1 Hans H. Schiffer (10660697) A1 Holly A. Reichard (2115589) A1 Shota Kikuchi (8968940) A1 Maria Hopkins (10660700) A1 Todd K. Macklin (2162785) A1 Stephen Hitchcock (2026327) A1 Mark Adams (26421) A1 Jason Green (10660703) A1 Jason Brown (253739) A1 Sean T. Murphy (123563) A1 Nidhi Kaushal (2449744) A1 Deanna R. Collia (10660706) A1 Steve Moore (2010817) A1 William J. Ray (190662) A1 Nicole Marion English (11098249) A1 Mark Beresford Lewis Carlton (10660709) A1 Nicola L. Brice (10660712) YR 2021 K1 Medicine K1 Neuroscience K1 Pharmacology K1 Biological Sciences not elsewhere classified K1 Chemical Sciences not elsewhere classified K1 GPR 6 activity K1 Selective GPR 6 Inverse Agonist K1 compound CVN 424. GPR 6 IAG K1 dopamine receptor D 2-type medium s K1 EC K1 vivo normalizes activity K1 Parkinson K1 GPR 6 K1 MSN K1 basal ganglia circuitry K1 6- OHDA-lesioned rat PD model K1 GPCR K1 GPR 6 IAG K1 striatal brain circuit K1 43 μ M JF https://figshare.com/articles/journal_contribution/First-Time_Disclosure_of_CVN424_a_Potent_and_Selective_GPR6_Inverse_Agonist_for_the_Treatment_of_Parkinson_s_Disease_Discovery_Pharmacological_Validation_and_Identification_of_a_Clinical_Candidate/14439410 LK http://dx.doi.org/https://doi.org/10.1021/acs.jmedchem.0c02081.s001 DO https://doi.org/10.1021/acs.jmedchem.0c02081.s001 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)